Clinical value of routine therapeutic anti-TNF drug monitoring (TDM) in Inflammatory Bowel Disease (IBD) patients in clinical practice

被引：0
|
作者：
Guirgis, M. [1 ]
Bianchetti, D. [2 ]
Dorta, G. [3 ]
Michetti, P. [1 ]
Maillard, M. [3 ]
机构：
[1] Crohns & Colitis Ctr, Gastroenterol, Lausanne, Switzerland
[2] Univ Lausanne, Gastroenterol & Hepatol, Lausanne, Switzerland
[3] CHU Vaudois, Gastroenterol & Hepatol, CH-1011 Lausanne, Switzerland
来源：
JOURNAL OF CROHNS & COLITIS | 2015年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P317
引用
收藏
页码：S235 / S236
页数：2
相关论文
共 50 条
  • [1] Clinical impact of routine anti-Tumour Necrosis Factor (anti-TNF) therapeutic drug monitoring (TDM) in the management of Inflammatory Bowel Disease (IBD) patients
    Guirgis, M.
    Bianchetti, D.
    Dorta, G.
    Michetti, P.
    Maillard, M.
    [J]. SWISS MEDICAL WEEKLY, 2015, 145 : S3 - S3
  • [2] Clinical Impact of Routine Anti-Tumour Necrosis Factor (Anti-TNF) Therapeutic Drug Monitoring (TDM) in Management of Inflammatory Bowel Disease (IBD) Patients
    Guirgis, Marianne
    Bianchetti, Davide
    Dorta, Gian O.
    Michetti, Pierre F.
    Maillard, Michel H.
    [J]. GASTROENTEROLOGY, 2015, 148 (04) : S857 - S858
  • [3] Is anti-TNF therapeutic drug monitoring of value in IBD patients in clinical remission?
    Subramaniam, K.
    Watthayalage, R.
    Neeman, T.
    Pavli, P.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 149 - 149
  • [4] Is anti-TNF therapeutic drug monitoring of value in IBD patients in clinical remission?
    Subramaniam, K.
    Watthayalage, R.
    Neeman, T.
    Pavli, P.
    [J]. JOURNAL OF CROHNS & COLITIS, 2017, 11 : S353 - S353
  • [5] Drug survival and reasons for discontinuation of anti-TNF therapy in inflammatory bowel disease (IBD) in clinical practice
    Gisbert, J. P.
    Arredondo, M.
    Chaparro, M.
    Canamares, I.
    Dauden, E.
    Fernandez-Jimenez, G.
    Meca, V.
    Morell, A.
    Carmona, L.
    Alvaro-Gracia, J. M.
    [J]. JOURNAL OF CROHNS & COLITIS, 2014, 8 : S279 - S279
  • [6] Clinical utility of routine measurement of Anti-TNF levels and their antibodies in inflammatory bowel disease (IBD)
    Sarwar, S.
    Foster, K.
    Corn, E.
    Moss, S.
    [J]. JOURNAL OF CROHNS & COLITIS, 2015, 9 : S297 - S297
  • [7] ATTITUDE AND BARRIERS TOWARDS THE IMPLEMENTATION OF THERAPEUTIC DRUG MONITORING OF ANTI-TNF THERAPY IN INFLAMMATORY BOWEL DISEASE CLINICAL PRACTICE
    Grossberg, Laurie B.
    Papamichail, Konstantinos
    Feuerstein, Joseph D.
    Cheifetz, Adam S.
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : S390 - S391
  • [8] Therapeutic Drug Monitoring of Anti-TNF Therapy in Inflammatory Bowel Disease
    Frank I. Scott
    Gary R. Lichtenstein
    [J]. Current Treatment Options in Gastroenterology, 2014, 12 (1) : 59 - 75
  • [9] Therapeutic drug monitoring of anti-TNF therapy in children with inflammatory bowel disease
    van Hoeve, Karen
    Hoffman, Ilse
    Vermeire, Severine
    [J]. EXPERT OPINION ON DRUG SAFETY, 2018, 17 (02) : 185 - 196
  • [10] Is the Therapeutic Drug Monitoring of Anti-TNF Agents Necessary in Korean Inflammatory Bowel Disease Patients?
    Eun, Chang Soo
    [J]. GUT AND LIVER, 2017, 11 (01) : 3 - 4
12345